Skip to main content

Advertisement

Log in

Clinical impact of cervical lymph node involvement and central neck dissection in patients with papillary thyroid carcinoma: a retrospective analysis of 368 cases

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

The impact of cervical lymph node metastases and the optimal surgical management of the neck in patients with papillary thyroid carcinoma (PTC) remain controversial. The objectives of this retrospective study were to determine, in patients with PTC, the predictive factors and the impact on tumor recurrence rate of cervical lymph node involvement, and to evaluate the oncologic results and the morbidity of central neck dissection (CND). We reviewed the records of patients who had undergone surgical treatment for PTC at our institution between 1990 and 2000. A total of 368 patients (86 men and 282 women) were included in this study. Young age (p = 0.02), tumor size (p = 0.001) and extrathyroidal tumor extension (p = 0.003) were significant predictive factors of cervical lymph node metastatic involvement (multivariate analysis). Initial metastatic cervical lymph node involvement was identified as an independent risk factor of tumor recurrence (multivariate analysis, p = 0.01). Metastatic lymph node(s) were found in prophylactic CND specimens in 31% of the patients. CND increased the risk of postoperative hypocalcemia (p = 0.008) and of permanent hypoparathyroidism (p = 0.002). In conclusion, cervical lymph node metastatic involvement at the time of initial surgery is an independent risk factor of tumor recurrence. CND provided an up-staging of more than 30% of patients with a clinically N0 neck, but was associated with significant morbidity regarding parathyroid function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Bibliography

  1. Pacini F, Castagna MG, Brilli L, Pentheroudakis G (2009) Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20 Suppl 4:143–146

    PubMed  CAS  Google Scholar 

  2. Shaha AR (2004) Prognostic factors in papillary thyroid carcinoma and implications of large nodal metastasis. Surgery 135:237–239

    Article  PubMed  Google Scholar 

  3. Shaha AR (2004) Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope 114:393–402

    Article  PubMed  Google Scholar 

  4. Shaha AR (2009) Prophylactic central compartment dissection in thyroid cancer: a new avenue of debate. Surgery 146:1224–1227

    Article  PubMed  Google Scholar 

  5. Zuniga S, Sanabria A (2009) Prophylactic central neck dissection in stage N0 papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 135:1087–1091

    Article  PubMed  Google Scholar 

  6. Rosenbaum MA, McHenry CR (2009) Central neck dissection for papillary thyroid cancer. Arch Otolaryngol Head Neck Surg 135:1092–1097

    Article  PubMed  Google Scholar 

  7. Shaha A (2006) Treatment of thyroid cancer based on risk groups. J Surg Oncol 94:683–691

    Article  PubMed  Google Scholar 

  8. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787–803

    Article  PubMed  CAS  Google Scholar 

  9. Machens A, Holzhausen HJ, Dralle H (2005) The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer 103:2269–2273

    Article  PubMed  Google Scholar 

  10. Ito Y, Jikuzono T, Higashiyama T, Asahi S, Tomoda C, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2006) Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg 30:1821–1828

    Article  PubMed  Google Scholar 

  11. Bozec A, Peyrottes I, Poissonnet G, Chamorey E, Mahdyoun P, Sudaka A, Ettore F, Benisvy D, Bussiere F, Marcy PY, Vallicioni J, Demard F, Jose S, Dassonville O (2009) Papillary thyroid microcarcinomas: review of 230 cases. Rev Laryngol Otol Rhinol (Bord) 130:215–220

    CAS  Google Scholar 

  12. Wada N, Masudo K, Nakayama H, Suganuma N, Matsuzu K, Hirakawa S, Rino Y, Masuda M, Imada T (2008) Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age. Eur J Surg Oncol 34:202–207

    PubMed  CAS  Google Scholar 

  13. Bozec A, Lassalle S, Hofman V, Ilie M, Santini J, Hofman P (2010) The thyroid gland: a crossroad in inflammation-induced carcinoma? An ongoing debate with new therapeutic potential. Curr Med Chem 17:3449–3461

    Article  PubMed  CAS  Google Scholar 

  14. Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP (1999) Coexistent Hashimoto’s thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery 126:1070–1076 (discussion 1076–1077)

    Article  PubMed  CAS  Google Scholar 

  15. Schlumberger M, Pacini F, Wiersinga WM, Toft A, Smit JW, Sanchez Franco F, Lind P, Limbert E, Jarzab B, Jamar F, Duntas L, Cohen O, Berg G (2004) Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice. Eur J Endocrinol 151:539–548

    Article  PubMed  CAS  Google Scholar 

  16. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214

    Article  PubMed  Google Scholar 

  17. Vergez S, Sarini J, Percodani J, Serrano E, Caron P (2010) Lymph node management in clinically node-negative patients with papillary thyroid carcinoma. Eur J Surg Oncol 36:777–782

    PubMed  CAS  Google Scholar 

  18. Moo TA, Umunna B, Kato M, Butriago D, Kundel A, Lee JA, Zarnegar R, Fahey TJ 3rd (2009) Ipsilateral versus bilateral central neck lymph node dissection in papillary thyroid carcinoma. Ann Surg 250:403–408

    PubMed  Google Scholar 

  19. Shaha AR (2008) Complications of neck dissection for thyroid cancer. Ann Surg Oncol 15:397–399

    Article  PubMed  Google Scholar 

  20. Clayman GL, Shellenberger TD, Ginsberg LE, Edeiken BS, El-Naggar AK, Sellin RV, Waguespack SG, Roberts DB, Mishra A, Sherman SI (2009) Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma. Head Neck 31:1152–1163

    Article  PubMed  Google Scholar 

  21. Roh JL, Park JY, Park CI (2007) Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg 245:604–610

    Article  PubMed  Google Scholar 

  22. White ML, Gauger PG, Doherty GM (2007) Central lymph node dissection in differentiated thyroid cancer. World J Surg 31:895–904

    Article  PubMed  Google Scholar 

  23. Giles Senyurek Y, Tunca F, Boztepe H, Alagol F, Terzioglu T, Tezelman S (2009) The long term outcome of papillary thyroid carcinoma patients without primary central lymph node dissection: expected improvement of routine dissection. Surgery 146:1188–1195

    Article  PubMed  Google Scholar 

  24. Monchik JM, Simon CJ, Caragacianu DL, Thomay AA, Tsai V, Cohen J, Mazzaglia PJ (2009) Does failure to perform prophylactic level VI node dissection leave persistent disease detectable by ultrasonography in patients with low-risk papillary carcinoma of the thyroid? Surgery 146:1182–1187

    Article  PubMed  Google Scholar 

  25. Mazzaferri EL, Doherty GM, Steward DL (2009) The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid 19:683–689

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Mrs. Maeva Maurin, Christine Lovera and Mr. Yann Chateau for their major contribution in the data management process of this study.

Conflict of interest

We have no conflict of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexandre Bozec.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bozec, A., Dassonville, O., Chamorey, E. et al. Clinical impact of cervical lymph node involvement and central neck dissection in patients with papillary thyroid carcinoma: a retrospective analysis of 368 cases. Eur Arch Otorhinolaryngol 268, 1205–1212 (2011). https://doi.org/10.1007/s00405-011-1639-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-011-1639-2

Keywords

Navigation